Glaxo

Head of U.S. clinical development program is David Richards, MD, who holds the title of senior VP-medical operations. Richards assumed that position last fall moving over from Glaxo Group Research, where he was a medical director. "The Pink Sheet" previously reported incorrectly that Peter Wise, MD, is head of the Glaxo, a medical director. "The Pink Sheet" previously reported incorrectly that Peter Wise, MD, is head of the Glaxo, Inc. clinical programs. Wise holds the title of senior VP-medical marketing and heads a research group that develops new uses for already marketed products as well as line extensions, dosage regimens, and new market niches.